Sanofi boosts Sanofi Ventures with additional $625 million September 24, 2025
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Second positive Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu in HER2-positive early breast cancer reinforces its potential to become a foundational treatment option in curative-intent setting
Harmonisation of listing structure requires a direct listing of AstraZeneca shares on the NYSE in place of existing US ADRs
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
New infrastructure makes it possible for healthcare organizations to integrate AI agents seamlessly into critical workflows like benefit verification and prior authorization
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Subscribe To Our Newsletter & Stay Updated